{"schema_version":"secwatch.filing_event.v1","accession":"0000856982-23-000046","form_type":"8-K","ticker":"MMSI","cik":"0000856982","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2023-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.798954+00:00","generated_at":"2026-06-13T03:45:00.803590+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Merit Medical Q2 2023 revenue $320.1M (+8.5% YoY); non-GAAP EPS $0.81 beat","bullets":["Q2 2023 revenue $320.1M, up 8.5% YoY; constant currency organic growth 9.1%.","GAAP EPS $0.35 vs $0.27; non-GAAP EPS $0.81 vs $0.73, both YoY increases.","GAAP operating margin 9.0% vs 7.9%; non-GAAP operating margin 19.9% vs 19.1%.","No guidance update; results reflect broad-based growth across product lines."],"urls":{"canonical":"https://secwatch.observer/filing/0000856982-23-000046","json":"https://secwatch.observer/filing/0000856982-23-000046.json","markdown":"https://secwatch.observer/filing/0000856982-23-000046.md","text":"https://secwatch.observer/filing/0000856982-23-000046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856982/000085698223000046/0000856982-23-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856982/000085698223000046/mmsi-20230725x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T03:45:00.803590+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c83a88f9c7bf8a87b854cdc1bb7581b3f8d84e49","claim":"MERIT MEDICAL SYSTEMS INC reported Q2 2023 results: revenue $320.1 million, EPS $0.35.","evidence_excerpt":"MERIT MEDICAL REPORTS RESULTS FOR SECOND QUARTER JUNE 30, 2023 ​ ● Q2 2023 reported revenue of $320.1 million, up 8.5% year-over-year ● Q2 2023 constant currency revenue* up 9.4% year over year ● Q2 2023 constant currency revenue, organic* up 9.1% year-over-year ● Q2 2023 GAAP operating margin of 9.0%, compared to 7.9% in Q2 2022 ● Q2 2023 non-GAAP operating margin* of 19.9%, compared to 19.1% in Q2 2022 ● Q2 2023 GAAP EPS $0.35, compared to $0.27 in Q2 2022 ● Q2 2023 non-GAAP EPS* of $0.81, compared to $0.73 in Q2 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698223000046/0000856982-23-000046-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Q2 2023"},{"label":"Revenue","value":"$320.1 million"},{"label":"EPS","value":"$0.35"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}